PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
* Age =\>18 years
* written informed consent
Exclusion Criteria:
* papillary cancer
* neuroendocrine pancreatic tumors
Primary outcome measure(s)
General assessment of applied therapy modalities in pancreatic cancer — First diagnose to death or end of surveillance (5 years after curative resection)
Quality of life in pancreatic cancer patients — First diagnose to death or end of surveillance (5 years after curative resection) EORTC QLQ c30 and PAN 26
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.